Two Sigma Investments, LP Oncocyte Corp Transaction History

Two Sigma Investments, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.15 - $2.25 $186,645 - $365,175	-162,300 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.04 - $3.59 $797,688 - $1.4 Million	-391,024 Reduced 70.67%	162,300 $352,000
Q3 2021 Nov 15, 2021	BUY	$3.53 - $5.89 $57,196 - $95,435	16,203 Added 3.02%	553,324 $1.97 Million
Q2 2021 Aug 16, 2021	BUY	$3.77 - $6.0 $435,732 - $693,474	115,579 Added 27.42%	537,121 $3.08 Million
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $1.01 Million - $2.74 Million	421,542 New	421,542 $2.19 Million
Q3 2020 Nov 16, 2020	SELL	$1.2 - $1.89 $227,578 - $358,436	-189,649 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.91 - $3.45 $337,399 - $609,439	176,649 Added 1358.84%	189,649 $362,000
Q1 2020 May 15, 2020	BUY	$1.76 - $3.02 $22,880 - $39,260	13,000 New	13,000 $32,000
Q4 2019 Feb 14, 2020	SELL	$1.51 - $2.27 $31,559 - $47,443	-20,900 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.59 - $2.51 $33,231 - $52,458	20,900 New	20,900 $44,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $326M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.